Tenaya Therapeutics Inc (TNYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -38,395 | -26,231 | N/A | N/A |
| Depreciation Amortization | 2,483 | 1,989 | N/A | N/A |
| Accounts payable and accrued liabilities | 142 | 397 | N/A | N/A |
| Other Working Capital | -234 | -250 | N/A | N/A |
| Other Operating Activity | 557 | -1 | 0 | 0 |
| Operating Cash Flow | $-35,447 | $-24,096 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | 2,753 | -2,657 | N/A | N/A |
| PPE Investments | -9,763 | -2,926 | N/A | N/A |
| Investing Cash Flow | $-7,010 | $-5,583 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 34 | 68 | N/A | N/A |
| Common Stock Repurchased | -1 | -3 | N/A | N/A |
| Other Financing Activity | 147,235 | 30,446 | 0 | 0 |
| Financing Cash Flow | $147,268 | $30,511 | $N/A | $N/A |
| Beginning Cash Position | 24,271 | 23,439 | N/A | N/A |
| End Cash Position | 129,082 | 24,271 | N/A | N/A |
| Net Cash Flow | $104,811 | $832 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -35,447 | -24,096 | N/A | N/A |
| Capital Expenditure | -9,763 | -2,926 | N/A | N/A |
| Free Cash Flow | -45,210 | -27,022 | 0 | 0 |